Cart
sales@molnova.com
ABL-IN-29
CAS No. 1430719-97-3
ABL-IN-29( —— )
Catalog No. M11821 CAS No. 1430719-97-3
ABL-IN-29 is a picomolar ABL kinase inhibitor with IC50 of 0.06/0.11 nM for wt ABL and ABL T315I respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameABL-IN-29
-
NoteResearch use only, not for human use.
-
Brief DescriptionABL-IN-29 is a picomolar ABL kinase inhibitor with IC50 of 0.06/0.11 nM for wt ABL and ABL T315I respectively.
-
DescriptionABL-IN-29 is a picomolar ABL kinase inhibitor with IC50 of 0.06/0.11 nM for wt ABL and ABL T315I respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetBcr-Abl
-
RecptorBcr-Abl
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1430719-97-3
-
Formula Weight327.402
-
Molecular FormulaC17H17N3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name1-ethyl-3-(6-(2-methoxyphenyl)benzo[d]thiazol-2-yl)urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Park H, et al. J Am Chem Soc. 2013 Jun 5;135(22):8227-37.
molnova catalog
related products
-
Lyn-IN-1
Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor.
-
WP1130
WP1130 (Degrasyn) is a small molecule that specifically and rapidly down-regulates both wild-type and mutant Bcr/Abl protein without affecting bcr/abl gene expression (IC50=1.8 uM).
-
DPH
A cell-permeable, small-molecule c-Abl kinase activator with pEC50 of 6.1(EC50=794 nM).
